Core facilities provide the wider research community with state-of-the-art instrumentation and expertise, improving research outcomes and furthering success with funding opportunities.
In order to measure the scientific impact from BCCHR Core Technologies and Services, we track and highlight such contributions to the wider research community. To achieve this, we require our collaborators to acknowledge the work performed by the BCCHR Core Technologies and Services in any or all of the following ways:
At a minimum, acknowledgement of the work of the BCCHR Core Technologies and Services should be included in peer-reviewed research publications. The following sentence can be incorporated into the acknowledgements section of the article:
“The authors wish to acknowledge BC Children’s Hospital Research Institute (BCCHR) Core Technologies and Services, Vancouver, Canada for [activity]."
In addition, acknowledgements should appear in the text of peer-reviewed publications. For example, in the materials and methods sections, a suggested sentence for inclusion is:
“[Activity] was performed at BC Children’s Hospital Research Institute (BCCHR) Core Technologies and Services, Vancouver, Canada.”
BCCHR Core Technologies and Services does not request or require co-authorship on publications when data has been generated through standard cost-recovery collaborative service alone (i.e. when no intellectual contribution has been made). Where intellectual contributions (i.e. designing experiments, assays, extensive data analysis, non-routine data analysis and interpretation) have been made by the BCCHR Core Technologies and Services staff, collaborators are requested to discuss potential contributions with the relevant staff/Core Technologies Office (core-tech@bcchr.ca) to identify appropriate co-authorship. Normally, simple acquisitions of raw data or routine sample preparations alone would not merit co-authorship but should still be acknowledged.
A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins.
The team, led by researchers from BC Children’s Hospital Research Institute and the University of British Columbia, is the first in Canada to combine these two techniques to identify and test a drug for a young patient's tumour in time for their treatment.
Pediatric nephrologist Dr. Susan Samuel, a new investigator who joined BCCHR in September 2024, has been investigating ways to improve the quality of life of children diagnosed with nephrotic syndrome. She is serving as the director for the ENRICH program, a national network of mentors and learners. We met Dr. Samuel to talk about the importance of research and mentorship.
BCCHR research highlights an exciting opportunity: schools can do more than deliver vaccines — they can spark knowledge! By integrating vaccine education into the curriculum, schools can boost confidence, empower students and families, and pave the way for stronger HPV vaccine uptake and cancer prevention.
A team of researchers at the Institute for Global Health (IGH) at BCCHR are leading an innovation that could have a positive impact on children worldwide. They have developed the RRate app, a mobile application that measures breathing rate and has been successfully used by frontline nurses in Uganda, a partner country of IGH. Widespread use of the app in low-resource settings could help save lives.
Congratulations to the investigators and their teams who were awarded funding through the Canadian Institutes of Health Research (CIHR) Fall 2024 Project Grant competition!
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.